| Lupin Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500257 |
NSE Symbol : LUPIN |
P/E(TTM) : 13.51 |
|
ISIN Demat : INE326A01037 |
Div & Yield% : 0.92 |
EPS(TTM) : 144.80 |
|
Book Value(₹) : 658.96 |
Market Cap(₹Cr) : 89,436.77 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 7,112.46 | 5,152.26 | 4,433.96 | 3,852.79 | 5,605.41 | 4,382.69 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 7,112.46 | 5,152.26 | 4,433.96 | 3,852.79 | 5,605.41 | 4,382.69 |
| Other Operating Income | 59.44 | 82.34 | 67.23 | 215.49 | 103.18 | 102.98 |
| Other Income | 102.48 | 536.56 | 99.80 | 662.68 | 54.14 | 48.79 |
| Total Income | 7,274.38 | 5,771.16 | 4,600.99 | 4,730.96 | 5,762.73 | 4,534.46 |
| Total Expenditure | 3,438.75 | 2,952.99 | 3,518.35 | 2,892.65 | 2,978.95 | 2,739.54 |
| PBIDT | 3,835.63 | 2,818.17 | 1,082.64 | 1,838.31 | 2,783.78 | 1,794.92 |
| Interest | 35.56 | 38.77 | 36.02 | 27.78 | 18.90 | 33.85 |
| PBDT | 3,800.07 | 2,779.40 | 1,046.62 | 1,810.53 | 2,764.88 | 1,761.07 |
| Depreciation | 190.01 | 177.05 | 178.68 | 174.72 | 176.73 | 207.98 |
| Tax | 892.57 | 471.12 | 141.40 | 287.23 | 451.54 | 270.25 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.89 | -32.46 | 9.09 | -8.77 | 8.54 | -8.51 |
| Reported Profit After Tax | 2,714.60 | 2,163.69 | 717.45 | 1,357.35 | 2,128.07 | 1,291.35 |
| Extra-ordinary Items | 0.00 | 366.67 | -523.94 | 488.61 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2,714.60 | 1,797.02 | 1,241.39 | 868.74 | 2,128.07 | 1,291.35 |
| EPS (Unit Curr.) | 59.37 | 37.01 | 15.71 | 29.72 | 46.60 | 28.30 |
| EPS (Adj) (Unit Curr.) | 59.37 | 37.01 | 15.71 | 29.72 | 46.60 | 28.30 |
| Calculated EPS (Unit Curr.) | 59.37 | 47.32 | 15.70 | 29.71 | 46.59 | 28.28 |
| Calculated EPS (Adj) (Unit Curr.) | 59.37 | 47.32 | 15.70 | 29.71 | 46.59 | 28.28 |
| Calculated EPS (Ann.) (Unit Curr.) | 237.47 | 189.30 | 62.82 | 118.86 | 186.37 | 113.13 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 237.47 | 189.30 | 62.82 | 118.86 | 186.37 | 113.13 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 91.45 | 91.44 | 91.37 | 91.36 | 91.35 | 91.32 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 53.93 | 54.70 | 24.42 | 47.71 | 49.66 | 40.95 |
| PBDTM(%) | 53.43 | 53.95 | 23.60 | 46.99 | 49.33 | 40.18 |
| PATM(%) | 38.17 | 41.99 | 16.18 | 35.23 | 37.96 | 29.46 |
